BET Protein Inhibition Relieves MDSC-Mediated Immune Suppression in Chronic Lymphocytic LeukemiaErin M. Drengler(University of Nebraska Medical Center), Dalia El-Gamal(University of Nebraska Medical Center)HematoMay 24, 202510.3390/hemato6020014Cited by 0SaveCiteExport RISWatch citationsRelated PapersImmunogenic Cell Death Traits Emitted from Chronic Lymphocytic Leukemia Cells Following Treatment with a Novel Anti-Cancer Agent, SpiD3|Biomedicines|2024|3